Cite
MLA Citation
Sally Moore et al.. “Weekly intravenous bortezomib is effective and well tolerated in relapsed/refractory myeloma.” European journal of haematology, vol. 90, n.d., pp. 420–425. http://access.bl.uk/ark:/81055/vdc_100024491983.0x00001b